CANF ▼ -13.1% - Can-Fite BioPharma Ltd. $CANF - Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds Can-Fite BioPharma fell 13.1% today following the company's announcement of a warrant exercise generating approximately $4.0 million in gross proceeds. While warrant exercises typically provide capital to the company, the significant stock decline suggests investors may have reacted negatively to the dilutive effect of the warrant conversion or broader market concerns about the company's equity structure. 02-SEP-2026 09:02 AM ET